Arman Haghighi, DDS
Oral and Maxillofacial Surgery · Boise, IDNPI 1124433743
Payments from drug & device makers
What this record shows
The money is spread across several categories — gifts (54.5%), food and beverage and education — rather than concentrated in one kind of arrangement. Straumann USA LLC accounts for 76.6% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2021 at $6,637 and has fallen 84.4% since, to $1,036 in 2025. Among oral and maxillofacial surgery clinicians in ID with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 108 payments — averaging $104.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Straumann USA LLC$9K
- Kls-martin L.p.$1K
- Nobel Biocare USA$307
- Zimmer Biomet$291
- Hu-friedy Mfg. Co., LLC$283
- AbbVie$210
- plus $323 from 6 others
What the payments were for
- Speaking & faculty fees$2312%
- Food & beverage$4,26238%
- Education$6586%
- Gifts$6,17455%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Straumann USA LLC | 63 | $8,680 |
| Kls-martin L.p. | 15 | $1,230 |
| Nobel Biocare USA | 7 | $307 |
| Zimmer Biomet | 6 | $291 |
| Hu-friedy Mfg. Co., LLC | 3 | $283 |
| AbbVie(2 entities) | 4 | $210 |
| Stryker | 3 | $135 |
| Henry Schein, Inc. | 2 | $62 |
| Dentsply Sirona Inc | 2 | $45 |
| Zimvie Inc. | 1 | $38 |
| Johnson & Johnson | 1 | $29 |
| Pacira Pharmaceuticals Incorporated | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,325 in reported general payments places this provider in the 95th percentile of 29 oral and maxillofacial surgery providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron OdtOndansetron | 144 | $1,355 |
| Chlorhexidine Gluconate | 285 | $994 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 193 | $826 |
| Amoxicillin | 189 | $488 |
| Clindamycin Hcl | 36 | $426 |
| Moxifloxacin Hcl | 11 | $284 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 31 | $255 |
Paid to pharmacies, not to this prescriber.
Other oral and maxillofacial surgery in Boise
- Justin HastingsBoise$5K
- Brian RowanBoise$4K
- Devan MunkBoise$3K
- Timothy O'BrienBoise$2K
- Kevin KempersBoise$1K
- Christopher ManisBoise$854
- Michael BaileyBoise$619
- James ComstockBoise$513
- Dean YounceBoise$179
- Bruce MorrisonBoise$62
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.